. Author manuscript; available in PMC: 2011 Jun 24.

Published in final edited form as: Acta Neuropathol. 2011 Jan 18;121(5):635–649. doi: 10.1007/s00401-011-0798-y

Table 1.

Demographic details of patients

	AD	PD/DLB	FTLD	PSP/CBD	MND	ND
Patients (n)	48	43	36	12	21	34
Age range (years)	50–92	54–89	31–80	64–91	45–72	26–94
Mean age ± SD (years)	71.7 ± 10.2	76.9 ± 7.7	63.9 ± 11.1	76.9 ± 10.6	61.7 ± 11.7	72.0 ± 20.1
Mean age at onset ± SD (years)	61.5 ± 11.4	63.9 ± 11.0	55.9 ± 11.6	69.3 ± 10.2	62.5 ± 3.5	–
Mean disease duration ± SD (years)	9.0 ± 3.5	13.2 ± 7.9	7.7 ± 4.5	7.7 ± 4.2	3.5 ± 2.1	–
Gender: male:female N (%)	17:26 (39.5:56.5)	32:9 (74.4:21.0)	21:12 (58.3:33.3)	10:2 (83:17)	13:7 (62:33)	11:21 (32.4:61.8)

AD Alzheimer’s disease, PD/DLB Parkinson’s disease/dementia with Lewy bodies, FTLD frontotemporal lobar degeneration, PSP/CBD progressive supranuclear palsy/corticobasal degeneration, MND motor neuron disease, ND non-demented